STIM
Neuronetics, Inc.Company Information
- Company Name
- Neuronetics, Inc.
- CIK
- CIK0001227636
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- STIM: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- STIM
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-14
- Last sale
- 2026-03-19
- Shares purchased (TTM)
- 2,784,914
- Shares sold (TTM)
- 192,210
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 36,951,316
- Shares outstanding
- 73,129,000
- Ownership
- 50.53%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- -9.72%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 19 | 13 | 28 | 28 | 11 | 20 | 18 | 21 | 43 | 48 | 60 | 36 | ||||||
| Restricted Cash And Cash Equivalents At Carrying Value | 6 | 6 | 6 | 7 | 7 | 1 | 1 | - | - | - | - | - | ||||||
| Restricted Cash Current | - | - | 1 | - | - | 1 | 1 | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | 16 | 16 | 16 | 19 | 26 | 26 | 23 | 17 | 17 | 18 | 16 | 15 | ||||||
| Inventory Net | 6 | 5 | 4 | 4 | 5 | 4 | 4 | 5 | 6 | 7 | 8 | 10 | ||||||
| Net Investment In Lease Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Prepaid Expense Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | ||||||
| Prepaid Expense And Other Assets Current | 4 | 4 | 3 | 4 | 4 | 5 | 7 | 5 | 4 | 4 | 5 | 5 | ||||||
| Assets Current | 53 | 47 | 62 | 65 | 56 | 61 | 58 | 53 | 76 | 82 | 94 | 71 | ||||||
| Property Plant And Equipment Net | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 2 | 2 | 2 | 2 | 2 | ||||||
| Goodwill | 24 | 24 | 24 | 23 | 19 | 19 | 19 | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 17 | 18 | 18 | 19 | 19 | 19 | 20 | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 24 | 23 | 24 | 24 | 24 | 27 | 27 | 2 | 2 | 3 | 3 | 3 | ||||||
| Net Investment In Lease Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Prepaid Expense Noncurrent | 7 | 7 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 8 | 8 | 8 | ||||||
| Notes And Loans Receivable Net Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 4 | 4 | 4 | ||||||
| Other Assets Noncurrent | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 4 | 4 | ||||||
| Assets | 132 | 125 | 142 | 145 | 135 | 142 | 141 | 74 | 97 | 104 | 116 | 93 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 12 | 11 | 11 | 12 | 10 | 8 | 11 | 3 | 4 | 3 | 5 | 3 | ||||||
| Accrued Liabilities Current | 9 | 10 | 12 | 10 | 11 | 9 | 13 | 11 | 9 | 9 | 13 | 10 | ||||||
| Deferred Revenue Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | ||||||
| Business Combination Contingent Consideration Liability Current | 0 | 0 | 1 | 1 | 1 | 1 | 1 | - | - | - | - | - | ||||||
| Other Liabilities Current | 0 | 1 | 1 | 0 | 0 | 0 | 1 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 1 | 1 | 1 | 1 | 1 | ||||||
| Long Term Debt Current | - | - | - | - | - | - | - | - | 14 | - | - | - | ||||||
| Liabilities Current | 28 | 28 | 31 | 29 | 28 | 25 | 31 | 17 | 29 | 14 | 20 | 15 | ||||||
| Long Term Debt Noncurrent | 62 | 61 | 66 | 66 | 56 | 55 | 55 | 46 | 46 | 59 | 59 | 37 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Deferred Revenue Noncurrent | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 20 | 19 | 19 | 19 | 20 | 22 | 23 | 2 | 2 | 2 | 2 | 3 | ||||||
| Liabilities | 110 | 108 | 115 | 114 | 103 | 102 | 109 | 65 | 77 | 76 | 82 | 55 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 490 | 482 | 480 | 478 | 469 | 467 | 447 | 416 | 413 | 411 | 410 | 408 | ||||||
| Retained Earnings Accumulated Deficit | -473 | -470 | -459 | -452 | -443 | -432 | -420 | -407 | -394 | -384 | -376 | -371 | ||||||
| Stockholders Equity | 22 | 13 | 22 | 31 | 27 | 40 | 28 | 9 | 19 | 28 | 34 | 38 | ||||||
| Minority Interest | 4 | 4 | 4 | 4 | 4 | 4 | 4 | - | - | - | - | - | ||||||
| Liabilities And Stockholders Equity | 132 | 125 | 142 | 145 | 135 | 142 | 141 | 74 | 97 | 104 | 116 | 93 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | - | - | - | 1 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 200 | 200 | 200 | 250 | 200 | ||||||
| Common Stock Shares Issued | 76 | 70 | 69 | 68 | 66 | 66 | 56 | 30 | 30 | 30 | 29 | 29 | ||||||
| Shares Outstanding | 76 | 70 | 69 | 68 | 66 | 66 | 56 | 30 | 30 | 30 | 29 | 29 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNeuronetics, Inc. (STIM) — SEC Financial Statements & Analysis
Neuronetics, Inc. (STIM) is a surgical & medical instruments & apparatus company, incorporated in DE. Neuronetics, Inc. trades on Nasdaq as: STIM. Neuronetics, Inc. (STIM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, Neuronetics, Inc. carries a market cap of $95.07M, a P/E ratio of -3.12x, a P/B ratio of 4.39x, a P/S ratio of 0.61x, an enterprise value of $131.64M, and an EV/EBITDA multiple of -6.67x. On profitability, it posts a gross margin of 49.12%, an operating margin of -14.74%, a net margin of -19.61%, a Return on Equity (ROE) of -124.71%, a Return on Assets (ROA) of -22.86%, and a Return on Invested Capital (ROIC) of -35.51%. Per share, it reports EPS of $-0.42, diluted EPS of $-0.42, free cash flow per share of $-0.15, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 39.59% year-over-year, net income growth of -37.68% year-over-year, and EPS growth of -43.60% year-over-year. On the balance sheet, it maintains a current ratio of 1.88x, a quick ratio of 1.59x, working capital of $24.92M, a debt-to-equity ratio of 5.08x, a debt ratio of 0.84, an interest coverage ratio of -3.47x, free cash flow of $-11.25M (TTM), and net debt of $36.57M. Figures sourced from SEC EDGAR.
- Market Cap
- $95.07M
- P/E TTM
- -3.12x
- EPS TTM
- $-0.42
- P/B TTM
- 4.39x
- ROE TTM
- -124.71%
- ROA TTM
- -22.86%
- Debt To Equity
- 5.08x
- Free Cash Flow TTM
- $-11.25M
- Net Revenue TTM Growth 1Y
- 39.59%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Neuronetics, Inc. in?
Neuronetics, Inc. (STIM) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does STIM trade on?
Neuronetics, Inc. (STIM) trades on the Nasdaq.
Where is Neuronetics, Inc. incorporated?
Neuronetics, Inc. is incorporated in DE.
When was Neuronetics, Inc. (STIM)'s most recent SEC filing?
Neuronetics, Inc. (STIM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is STIM's market cap?
Neuronetics, Inc. (STIM) has a market capitalization of $95.07M as of 2026-06-30.
What is STIM's EPS (earnings per share)?
Neuronetics, Inc. (STIM)'s trailing twelve month EPS is $-0.42 as of 2026-06-30.
What is STIM's ROE (return on equity)?
Neuronetics, Inc. (STIM)'s trailing twelve month Return on Equity (ROE) is -124.71% as of 2026-06-30.
What is STIM's ROA (return on assets)?
Neuronetics, Inc. (STIM)'s trailing twelve month Return on Assets (ROA) is -22.86% as of 2026-06-30.
What is STIM's ROIC (return on invested capital)?
Neuronetics, Inc. (STIM)'s trailing twelve month Return on Invested Capital (ROIC) is -35.51% as of 2026-06-30.
What is STIM's EV/EBITDA?
Neuronetics, Inc. (STIM)'s trailing twelve month EV/EBITDA is -6.67x as of 2026-06-30.